1 Market Overview
1.1 Nivolumab Introduction
1.2 Market Analysis by Type
1.2.1 Injection 4mL
1.2.2 Injection 10mL
1.3 Market Analysis by Applications
1.3.1 Unresectable Melanoma
1.3.2 Metastatic Melanoma
1.3.3 Metastatic Squamous NSCLC
1.3.4 Classical Hodgkin Lymphoma
1.3.5 Renal Cell Carcinoma
1.3.6 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Ono Pharmaceutical
2.1.1 Business Overview
2.1.2 Nivolumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Ono Pharmaceutical Nivolumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Nivolumab Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Nivolumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Nivolumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Nivolumab Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Nivolumab Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nivolumab Manufacturer Market Share in 2019
3.3.2 Top 6 Nivolumab Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Nivolumab Market Analysis by Regions
4.1 Global Nivolumab Sales, Revenue and Market Share by Regions
4.1.1 Global Nivolumab Sales and Market Share by Regions (2015-2019)
4.1.2 Global Nivolumab Revenue and Market Share by Regions (2015-2019)
4.2 North America Nivolumab Sales and Growth Rate (2015-2019)
4.3 Europe Nivolumab Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Nivolumab Sales and Growth Rate (2015-2019)
4.5 South America Nivolumab Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Nivolumab Sales and Growth Rate (2015-2019)
5 North America Nivolumab by Country
5.1 North America Nivolumab Sales, Revenue and Market Share by Country
5.1.1 North America Nivolumab Sales and Market Share by Country (2015-2019)
5.1.2 North America Nivolumab Revenue and Market Share by Country (2015-2019)
5.2 United States Nivolumab Sales and Growth Rate (2015-2019)
5.3 Canada Nivolumab Sales and Growth Rate (2015-2019)
5.4 Mexico Nivolumab Sales and Growth Rate (2015-2019)
6 Europe Nivolumab by Country
6.1 Europe Nivolumab Sales, Revenue and Market Share by Country
6.1.1 Europe Nivolumab Sales and Market Share by Country (2015-2019)
6.1.2 Europe Nivolumab Revenue and Market Share by Country (2015-2019)
6.2 Germany Nivolumab Sales and Growth Rate (2015-2019)
6.3 UK Nivolumab Sales and Growth Rate (2015-2019)
6.4 France Nivolumab Sales and Growth Rate (2015-2019)
6.5 Russia Nivolumab Sales and Growth Rate (2015-2019)
6.6 Italy Nivolumab Sales and Growth Rate (2015-2019)
7 Asia-Pacific Nivolumab by Country
7.1 Asia-Pacific Nivolumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Nivolumab Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Nivolumab Revenue and Market Share by Country (2015-2019)
7.2 China Nivolumab Sales and Growth Rate (2015-2019)
7.3 Japan Nivolumab Sales and Growth Rate (2015-2019)
7.4 Korea Nivolumab Sales and Growth Rate (2015-2019)
7.5 India Nivolumab Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Nivolumab Sales and Growth Rate (2015-2019)
8 South America Nivolumab by Country
8.1 South America Nivolumab Sales, Revenue and Market Share by Country
8.1.1 South America Nivolumab Sales and Market Share by Country (2015-2019)
8.1.2 South America Nivolumab Revenue and Market Share by Country (2015-2019)
8.2 Brazil Nivolumab Sales and Growth Rate (2015-2019)
8.3 Argentina Nivolumab Sales and Growth Rate (2015-2019)
8.4 Colombia Nivolumab Sales and Growth Rate (2015-2019)
9 Middle East and Africa Nivolumab by Countries
9.1 Middle East and Africa Nivolumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Nivolumab Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Nivolumab Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Nivolumab Sales and Growth Rate (2015-2019)
9.3 Turkey Nivolumab Sales and Growth Rate (2015-2019)
9.4 Egypt Nivolumab Sales and Growth Rate (2015-2019)
9.5 Nigeria Nivolumab Sales and Growth Rate (2015-2019)
9.6 South Africa Nivolumab Sales and Growth Rate (2015-2019)
10 Global Nivolumab Market Segment by Type
10.1 Global Nivolumab Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Nivolumab Sales and Market Share by Type (2015-2019)
10.1.2 Global Nivolumab Revenue and Market Share by Type (2015-2019)
10.2 Injection 4mL Sales Growth and Price
10.2.1 Global Injection 4mL Sales Growth (2015-2019)
10.2.2 Global Injection 4mL Price (2015-2019)
10.3 Injection 10mL Sales Growth and Price
10.3.1 Global Injection 10mL Sales Growth (2015-2019)
10.3.2 Global Injection 10mL Price (2015-2019)
11 Global Nivolumab Market Segment by Application
11.1 Global Nivolumab Sales Market Share by Application (2015-2019)
11.2 Unresectable Melanoma Sales Growth (2015-2019)
11.3 Metastatic Melanoma Sales Growth (2015-2019)
11.4 Metastatic Squamous NSCLC Sales Growth (2015-2019)
11.5 Classical Hodgkin Lymphoma Sales Growth (2015-2019)
11.6 Renal Cell Carcinoma Sales Growth (2015-2019)
11.7 Other Sales Growth (2015-2019)
12 Nivolumab Market Forecast (2020-2025)
12.1 Global Nivolumab Sales, Revenue and Growth Rate (2020-2025)
12.2 Nivolumab Market Forecast by Regions (2020-2025)
12.2.1 North America Nivolumab Market Forecast (2020-2025)
12.2.2 Europe Nivolumab Market Forecast (2020-2025)
12.2.3 Asia-Pacific Nivolumab Market Forecast (2020-2025)
12.2.4 South America Nivolumab Market Forecast (2020-2025)
12.2.5 Middle East and Africa Nivolumab Market Forecast (2020-2025)
12.3 Nivolumab Market Forecast by Type (2020-2025)
12.3.1 Global Nivolumab Sales Forecast by Type (2020-2025)
12.3.2 Global Nivolumab Market Share Forecast by Type (2020-2025)
12.4 Nivolumab Market Forecast by Application (2020-2025)
12.4.1 Global Nivolumab Sales Forecast by Application (2020-2025)
12.4.2 Global Nivolumab Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
